Jovanka Vasilevska-Ristovska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jovanka Vasilevska-Ristovska has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Rulan Savita Parekh
Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada
3 shared publications - Cal H. Robinson
Division of Nephrology, the Hospital for Sick Children, Toronto, Canada
2 shared publications - Chia Wei Teoh
Division of Pediatric Nephrology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
2 shared publications Jessica Fitzpatrick
Child Health Evaluative Sciences Research Institute, Hospital for Sick Children Toronto Canada
2 shared publicationsTonny Banh
Child Health Evaluative Sciences Research Institute, Hospital for Sick Children Toronto Canada
2 shared publicationsAlisha Parikh
Child Health Evaluative Sciences Research Institute, Hospital for Sick Children Toronto Canada
1 shared publication
Latest Publications
- 23 May 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (5) , e70343
Ionizing Radiation Exposure From Imaging in Pediatric Solid Organ Transplant Recipients
Background: Pediatric solid organ transplant recipients undergo extensive medical imaging. Limited data are available on the cumulative radiation dose from imaging. Our aim was to quantify cumulative ionizing radiation exposure and define its contributors. Methods: Retrospective cohort study of children (0–18 years) who received their first solid organ transplant (heart, lung, liver, kidney, or multi‐organ) at a tertiary care children's hospital in Toronto, Canada over a 10‐year period. Participants were followed from their first imaging procedure pre‐transplantation until transfer of care, death, or 28‐months after enrollment. The primary outcome was cumulative effective dose (CED; in millisieverts [mSv]) of ionizing radiation. CED estimates were stratified by era (pre‐ and post‐transplant), imaging modality, imaging indication, and transplant organ group. Results: Among 543 pediatric solid organ transplant recipients, 29 821 imaging studies were conducted over median 3.4‐year (IQR 1.0–6.1) follow‐up. Median estimated CED was 21 mSv (IQR 9–41) and median 39 (IQR 20–71) imaging studies were performed per child. Throughout follow‐up, 259 (48%) children were exposed to a CED ≤ 20 mSv, 168 (31%) to 20–50 mSv, 71 (13%) to 50–100 mSv, and 45 (8%) to > 100 mSv. Computed tomography was the highest contributor to CED (44%), with most studies performed for clinical care. Only 20% of CED was attributable to planned per‐protocol imaging. Radiation exposure was highest in multi‐organ transplant recipients and lowest in kidney recipients. Conclusions: Radiation exposure from medical imaging was low‐to‐moderate for most pediatric solid organ transplant recipients. Emphasis on optimizing ionizing modalities to reduce radiation dose and the promotion of non‐ionizing imaging modalities remains important.
- 23 May 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (5) , e70343
Ionizing Radiation Exposure From Imaging in Pediatric Solid Organ Transplant Recipients
Background: Pediatric solid organ transplant recipients undergo extensive medical imaging. Limited data are available on the cumulative radiation dose from imaging. Our aim was to quantify cumulative ionizing radiation exposure and define its contributors. Methods: Retrospective cohort study of children (0–18 years) who received their first solid organ transplant (heart, lung, liver, kidney, or multi‐organ) at a tertiary care children's hospital in Toronto, Canada over a 10‐year period. Participants were followed from their first imaging procedure pre‐transplantation until transfer of care, death, or 28‐months after enrollment. The primary outcome was cumulative effective dose (CED; in millisieverts [mSv]) of ionizing radiation. CED estimates were stratified by era (pre‐ and post‐transplant), imaging modality, imaging indication, and transplant organ group. Results: Among 543 pediatric solid organ transplant recipients, 29 821 imaging studies were conducted over median 3.4‐year (IQR 1.0–6.1) follow‐up. Median estimated CED was 21 mSv (IQR 9–41) and median 39 (IQR 20–71) imaging studies were performed per child. Throughout follow‐up, 259 (48%) children were exposed to a CED ≤ 20 mSv, 168 (31%) to 20–50 mSv, 71 (13%) to 50–100 mSv, and 45 (8%) to > 100 mSv. Computed tomography was the highest contributor to CED (44%), with most studies performed for clinical care. Only 20% of CED was attributable to planned per‐protocol imaging. Radiation exposure was highest in multi‐organ transplant recipients and lowest in kidney recipients. Conclusions: Radiation exposure from medical imaging was low‐to‐moderate for most pediatric solid organ transplant recipients. Emphasis on optimizing ionizing modalities to reduce radiation dose and the promotion of non‐ionizing imaging modalities remains important.
- Open Access
- 8 December 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (8) , e70245
Validating Recipients of Pediatric Solid Organ Transplant Using Administrative Healthcare Data
Background: Health administrative datasets have the potential to provide valuable insights into pediatric solid organ transplantation; however, validation is necessary to ensure their accuracy. This study aimed to assess the validity of administrative data by comparing it to direct transplant records from a major pediatric transplant center in Ontario, Canada (1991–2011). Methods: Using linked administrative healthcare databases, we conducted a retrospective analysis to evaluate the validity of physician billing claims and hospital diagnostic and procedural codes in identifying pediatric solid organ transplants. Sensitivity and positive predictive value (PPV) were calculated for various algorithms. Results: During the study period, a total of 347 kidney, 250 liver, 200 heart, and 28 lung transplants were performed. The best algorithm for identifying these transplants utilized hospital procedural codes from the Canadian Institute for Health Information Discharge Abstract Database. Compared to transplant center records, these codes demonstrated a sensitivity of 91% (95% CI: 89–93) and PPV of 93% (95% CI: 91–95) when including all organ types, and performed similarly well when evaluating individual organ types. Conclusion: This study is the first to validate administrative data for identifying pediatric solid organ transplant recipients, demonstrating the reliability of procedural codes for population‐level health research in this domain.
- 8 December 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (8) , e70245
Open AccessValidating Recipients of Pediatric Solid Organ Transplant Using Administrative Healthcare Data
Background: Health administrative datasets have the potential to provide valuable insights into pediatric solid organ transplantation; however, validation is necessary to ensure their accuracy. This study aimed to assess the validity of administrative data by comparing it to direct transplant records from a major pediatric transplant center in Ontario, Canada (1991–2011). Methods: Using linked administrative healthcare databases, we conducted a retrospective analysis to evaluate the validity of physician billing claims and hospital diagnostic and procedural codes in identifying pediatric solid organ transplants. Sensitivity and positive predictive value (PPV) were calculated for various algorithms. Results: During the study period, a total of 347 kidney, 250 liver, 200 heart, and 28 lung transplants were performed. The best algorithm for identifying these transplants utilized hospital procedural codes from the Canadian Institute for Health Information Discharge Abstract Database. Compared to transplant center records, these codes demonstrated a sensitivity of 91% (95% CI: 89–93) and PPV of 93% (95% CI: 91–95) when including all organ types, and performed similarly well when evaluating individual organ types. Conclusion: This study is the first to validate administrative data for identifying pediatric solid organ transplant recipients, demonstrating the reliability of procedural codes for population‐level health research in this domain.
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (12) , 1767-1779
Challenging Clinical Practice Guideline Definitions in Childhood Nephrotic Syndrome
Key Points: Three quarters of children with steroid-resistant nephrotic syndrome respond to other immunosuppression and have good kidney outcomes. Children classified as frequently relapsing by International Pediatric Nephrology Association versus Kidney Disease Improving Global Outcomes criteria have similar relapse rates and risk of CKD. These findings support defining treatment resistance by response to any immunosuppression and implementing the International Pediatric Nephrology Association criteria for frequent relapses. Background: In childhood nephrotic syndrome, definitions of immunosuppression response, frequently relapsing nephrotic syndrome (FRNS), and long-term remission are conflicting and based on limited evidence. Our goal was to define treatment response, FRNS, and long-term remission on the basis of associated disease outcomes. Methods: We included children (6 months–18 years) diagnosed with nephrotic syndrome between 1993 and 2023 in combined Canadian cohorts. We evaluated different definitions of ( 1 ) immunosuppressive treatment response, ( 2 ) FRNS, including Kidney Disease Improving Global Outcomes (KDIGO) 2021 and International Pediatric Nephrology Association (IPNA) 2023 criteria, and ( 3 ) long-term remission. Outcomes were time to CKD, relapse count throughout follow-up, and time to relapse, analyzed by Cox proportional hazards and negative binomial regression. Results: We included 1114 children with nephrotic syndrome (median age at diagnosis, 3.8 years; 63% male; median follow-up, 4.7 years). Among them, 1054 (95%) were steroid sensitive, 60 (5%) were steroid resistant (steroid-resistant nephrotic syndrome [SRNS]), and 73% with SRNS achieved complete remission with steroid-sparing immunosuppression. No child with treatment-responsive SRNS developed CKD. Within 1 year of diagnosis, 281 steroid-sensitive children (27%) were classified with FRNS by KDIGO and 383 (36%) by IPNA criteria. Children with FRNS by IPNA criteria (versus KDIGO) had a similar number of relapses (adjusted rate ratio, 0.95; 95% confidence interval, 0.81 to 1.12) and CKD risk (2% each) but less often received steroid-sparing immunosuppression (hazard ratio, 0.42; 95% confidence interval, 0.32 to 0.56). Ninety-eight percent of relapses occur within 3 years of the initial diagnosis or the last relapse event. Conclusions: Children with SRNS who achieve remission have a similar CKD risk to steroid-sensitive children. Children with FRNS by IPNA 2023 and KDIGO 2021 criteria experience similar rates of relapse and CKD. This supports defining treatment resistance by response to any immunosuppressive medication, implementation of the IPNA FRNS criteria, and use of 3-year relapse-free survival as a surrogate for long-term remission.
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (12) , 1767-1779
Challenging Clinical Practice Guideline Definitions in Childhood Nephrotic Syndrome
Key Points: Three quarters of children with steroid-resistant nephrotic syndrome respond to other immunosuppression and have good kidney outcomes. Children classified as frequently relapsing by International Pediatric Nephrology Association versus Kidney Disease Improving Global Outcomes criteria have similar relapse rates and risk of CKD. These findings support defining treatment resistance by response to any immunosuppression and implementing the International Pediatric Nephrology Association criteria for frequent relapses. Background: In childhood nephrotic syndrome, definitions of immunosuppression response, frequently relapsing nephrotic syndrome (FRNS), and long-term remission are conflicting and based on limited evidence. Our goal was to define treatment response, FRNS, and long-term remission on the basis of associated disease outcomes. Methods: We included children (6 months–18 years) diagnosed with nephrotic syndrome between 1993 and 2023 in combined Canadian cohorts. We evaluated different definitions of ( 1 ) immunosuppressive treatment response, ( 2 ) FRNS, including Kidney Disease Improving Global Outcomes (KDIGO) 2021 and International Pediatric Nephrology Association (IPNA) 2023 criteria, and ( 3 ) long-term remission. Outcomes were time to CKD, relapse count throughout follow-up, and time to relapse, analyzed by Cox proportional hazards and negative binomial regression. Results: We included 1114 children with nephrotic syndrome (median age at diagnosis, 3.8 years; 63% male; median follow-up, 4.7 years). Among them, 1054 (95%) were steroid sensitive, 60 (5%) were steroid resistant (steroid-resistant nephrotic syndrome [SRNS]), and 73% with SRNS achieved complete remission with steroid-sparing immunosuppression. No child with treatment-responsive SRNS developed CKD. Within 1 year of diagnosis, 281 steroid-sensitive children (27%) were classified with FRNS by KDIGO and 383 (36%) by IPNA criteria. Children with FRNS by IPNA criteria (versus KDIGO) had a similar number of relapses (adjusted rate ratio, 0.95; 95% confidence interval, 0.81 to 1.12) and CKD risk (2% each) but less often received steroid-sparing immunosuppression (hazard ratio, 0.42; 95% confidence interval, 0.32 to 0.56). Ninety-eight percent of relapses occur within 3 years of the initial diagnosis or the last relapse event. Conclusions: Children with SRNS who achieve remission have a similar CKD risk to steroid-sensitive children. Children with FRNS by IPNA 2023 and KDIGO 2021 criteria experience similar rates of relapse and CKD. This supports defining treatment resistance by response to any immunosuppressive medication, implementation of the IPNA FRNS criteria, and use of 3-year relapse-free survival as a surrogate for long-term remission.
- 1 August 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (8) , 1680-1689
Longitudinal Changes in Cardiac Structure and Function in Pediatric Kidney Transplant Recipients
Background: Cardiovascular disease results in increased morbidity and mortality in pediatric kidney transplant recipients. Longitudinal changes in cardiac structure and function and the association with blood pressure control over time in pediatric kidney transplant recipients are unknown. Methods: To determine the influence of blood pressure control on cardiac changes following pediatric kidney transplant, we conducted a retrospective cohort study of children who received their first kidney transplant at the Hospital for Sick Children from 2004 to 2015. Children were followed until transfer to adult care or censoring in July 2018. Cardiac structure and function parameters were collected from clinical echocardiograms and assessed using standardized scores. Blood pressure control was determined by systolic blood pressure Z scores (above or below the 90th percentile) in combination with antihypertensive medications. A segmented mixed-effects model assessed Z scores of interventricular septum thickness, left ventricular end-diastolic dimension, and left ventricular posterior wall dimension. Results: Of 142 children included, 58% were men, mean age at transplant was 11 (±4.5) years, and average follow-up time was 4 (±3) years. All cardiac structural Z scores improved during follow-up. Interventricular septum thickness normalized at 4.0 years post-transplant. Left ventricular end-diastolic dimension normalized at 1.5 years post-transplant. Left ventricular posterior wall dimension normalized at 6.3 years post-transplant. Left ventricular mass index showed sustained improvement up to 12 years post-transplant. Individuals with uncontrolled blood pressure had increased left ventricular mass (β=2.97 [95% CI, 0.77–5.16]). Conclusions: Cardiac structural abnormalities improve following kidney transplantation and normalize within 7 years, especially with controlled blood pressure. Strict blood pressure control is critical after pediatric kidney transplantation. Download figure Download PowerPoint
- 1 August 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (8) , 1680-1689
Longitudinal Changes in Cardiac Structure and Function in Pediatric Kidney Transplant Recipients
Background: Cardiovascular disease results in increased morbidity and mortality in pediatric kidney transplant recipients. Longitudinal changes in cardiac structure and function and the association with blood pressure control over time in pediatric kidney transplant recipients are unknown. Methods: To determine the influence of blood pressure control on cardiac changes following pediatric kidney transplant, we conducted a retrospective cohort study of children who received their first kidney transplant at the Hospital for Sick Children from 2004 to 2015. Children were followed until transfer to adult care or censoring in July 2018. Cardiac structure and function parameters were collected from clinical echocardiograms and assessed using standardized scores. Blood pressure control was determined by systolic blood pressure Z scores (above or below the 90th percentile) in combination with antihypertensive medications. A segmented mixed-effects model assessed Z scores of interventricular septum thickness, left ventricular end-diastolic dimension, and left ventricular posterior wall dimension. Results: Of 142 children included, 58% were men, mean age at transplant was 11 (±4.5) years, and average follow-up time was 4 (±3) years. All cardiac structural Z scores improved during follow-up. Interventricular septum thickness normalized at 4.0 years post-transplant. Left ventricular end-diastolic dimension normalized at 1.5 years post-transplant. Left ventricular posterior wall dimension normalized at 6.3 years post-transplant. Left ventricular mass index showed sustained improvement up to 12 years post-transplant. Individuals with uncontrolled blood pressure had increased left ventricular mass (β=2.97 [95% CI, 0.77–5.16]). Conclusions: Cardiac structural abnormalities improve following kidney transplantation and normalize within 7 years, especially with controlled blood pressure. Strict blood pressure control is critical after pediatric kidney transplantation. Download figure Download PowerPoint